ESTRADIOL HEMIHYDRATE/NORETHISTERONE ACETATE/RELUGOLIX (Ryeqo ®)

Clinical Indication

For treating moderate to severe symptoms of uterine fibroids in adults of reproductive age.

Comments

Treatment for 6-12 months at the direction of specialist team. In line with NICE TA832

classification or pathway

Date of classification

December 2022

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .